White Paper: Electronic Drug Accountability Systems
The increase in federal audits and the growing federal regulations has made drug accountability management a major challenge. A failed federal audit leads to costly trial delays, and possibly non-approval or criminal liability. Electronic drug accountability managed through an IRT system can ensure compliance, reduce inefficiencies, preserve data integrity and increase patient safety.
This white paper examines how electronic drug accountability managed through an IRT system:
Improves protocol compliance
Reduces clinical trial inefficiencies
Preserves study data integrity
Increases patient safety